Cargando…
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA
Circulating tumour DNA (ctDNA) can detect and profile residual tumour cells persisting after curative intent therapy(1). Large patient cohorts incorporating longitudinal plasma sampling and extended follow-up are required to determine the role of ctDNA as a phylogenetic biomarker of relapse in early...
Ejemplares similares
-
Evolutionary characterisation of lung adenocarcinoma morphology in TRACERx
por: Karasaki, Takahiro, et al.
Publicado: (2023) -
Body composition and lung cancer-associated cachexia in TRACERx
por: Al-Sawaf, Othman, et al.
Publicado: (2023) -
The evolution of lung cancer and impact of subclonal selection in TRACERx
por: Frankell, Alexander M., et al.
Publicado: (2023) -
The evolution of non-small cell lung cancer metastases in TRACERx
por: Al Bakir, Maise, et al.
Publicado: (2023) -
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
por: Jamal-Hanjani, Mariam, et al.
Publicado: (2014)